ClinicalTrials.Veeva

Menu

Effects of Physical Exercise on Cardio-vascular Efficiency and Quality of Life in Breast Cancer Survivors

I

ITAB - Institute for Advanced Biomedical Technologies

Status

Completed

Conditions

Breast Cancer Female

Treatments

Other: Physical exercise

Study type

Interventional

Funder types

Other

Identifiers

NCT04337736
BCSPHE001

Details and patient eligibility

About

To examine the effects of different physical exercise protocols (aerobic training and resistance training) on cardio-vascular efficiency and quality of life in a population of breast cancer survivors (BCS), not treated with chemotherapy.

Full description

The present study enrolled a population of BCS women who underwent surgical treatment for breast cancer at the "Ospedale G. Bernabeo" of Ortona, Chieti, Italy. The participants were randomized to the following physical exercise protocols: aerobic training, walking or Nordic walking; resistance training.

All the participants have been examined utilizing transthoracic echocardiography, carotid ultrasound and photo-plethysmographic method for the analysis of arterial stiffness, before and after the physical exercise protocol (T0-T1). The two-dimensional speckle-tracking analysis was performed with an offline, dedicated software from the apical 4-chambers-view. Moreover, ventricular-arterial coupling, epicardial fat thickness and intima-media thickness were also analyzed.

Quality of life was assessed using SF-36 score at T0, T1 and at a mean follow-up of 34 months. Moreover, at follow-up, we evaluated spontaneous physical activity and cardiovascular quality of life using IPAQ and SAQ-7 scores.

Enrollment

57 patients

Sex

Female

Ages

Under 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • age < 65 years;
  • history of breast cancer surgery in the previous 12 months;
  • no history of chemotherapy;
  • no ongoing radiotherapy;
  • eventual hormonal therapy;
  • cardiovascular and orthopedic eligibility.

Exclusion criteria

  • adjuvant chemotherapy;
  • any history of cardiovascular disease;
  • abnormal exercise stress test at the screening;
  • any systemic inflammatory disease or any orthopedic condition potentially limiting the physical training.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

57 participants in 2 patient groups

Aerobic training
Active Comparator group
Description:
12-weeks, 3-days-a week, supervised aerobic (Nordic walking or Walking) physical exercise (PhE) protocol; duration of each PhE session: 70 minutes; rate of perceived exertion (RPE): 10-11 (1st-4th week); 12-13 (5th-8th week); 13-14 (9th-12th week).
Treatment:
Other: Physical exercise
Resistance training
Active Comparator group
Description:
12-weeks, 2.3-days-a week (total of 28 lessons), supervised resistance physical exercise (PhE) protocol; duration of each PhE session: 50 minutes.
Treatment:
Other: Physical exercise

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems